Role of HER receptors family in development and differentiation

被引:194
作者
Casalini, P [1 ]
Iorio, MV [1 ]
Galmozzi, E [1 ]
Ménard, S [1 ]
机构
[1] Ist Nazl Tumori, Mol Targeting Unit, Dept Expt Oncol, I-20133 Milan, Italy
关键词
D O I
10.1002/jcp.20007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Members of the epidermal growth factor receptor family of receptor tyrosine kinases play a critical role in both development and oncogenesis. The latter is suggested by the frequent overexpression of HER-2, EGFR, and HER-3 in some human carcinomas, primarily breast and squamous cancer. The biological activities of the EGFR family are exerted through various ligand-receptor and receptor-receptor interactions. One receptor that plays a central role in this signaling network is HER-2/Neu, which is considered the preferred heterodimerization partner for other members of the EGFR family. The role of these receptors and their ligands in development is discussed, with particular emphasis on their ability to mediate a variety of pathways and cellular responses, including proliferation, differentiation, and apoptosis. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 80 条
  • [41] EGF receptor: which way to go?
    Lehto, VP
    [J]. FEBS LETTERS, 2001, 491 (1-2) : 1 - 3
  • [42] Inhibition of erbB receptor family members protects HaCaT keratinocytes, from ultraviolet-B-induced apoptosis
    Lewis, DA
    Zweig, B
    Hurwitz, SA
    Spandau, DF
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (03) : 483 - 488
  • [43] Stat5a is mandatory for adult mammary gland development and lactogenesis
    Liu, XW
    Robinson, GW
    Wagner, KU
    Garrett, L
    WynshawBoris, A
    Hennighausen, L
    [J]. GENES & DEVELOPMENT, 1997, 11 (02) : 179 - 186
  • [44] Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5
    Long, WW
    Wagner, KU
    Lloyd, KCK
    Binart, N
    Shillingford, JM
    Hennighausen, L
    Jones, FE
    [J]. DEVELOPMENT, 2003, 130 (21): : 5257 - 5268
  • [45] THE MOUSE WAVED-2 PHENOTYPE RESULTS FROM A POINT MUTATION IN THE EGF RECEPTOR TYROSINE KINASE
    LUETTEKE, NC
    PHILLIPS, HK
    QIU, TH
    COPELAND, NG
    EARP, HS
    JENKINS, NA
    LEE, DC
    [J]. GENES & DEVELOPMENT, 1994, 8 (04) : 399 - 413
  • [46] Manegold C, 2003, ADV EXP MED BIOL, V532, P247
  • [47] GLIAL GROWTH-FACTORS ARE ALTERNATIVELY SPLICED ERBB2 LIGANDS EXPRESSED IN THE NERVOUS-SYSTEM
    MARCHIONNI, MA
    GOODEARL, ADJ
    CHEN, MS
    BERMINGHAMMCDONOGH, O
    KIRK, C
    HENDRICKS, M
    DANEHY, F
    MISUMI, D
    SUDHALTER, J
    KOBAYASHI, K
    WROBLEWSKI, D
    LYNCH, C
    BALDASSARE, M
    HILES, I
    DAVIS, JB
    HSUAN, JJ
    TOTTY, NF
    OTSU, M
    MCBURNEY, RN
    WATERFIELD, MD
    STROOBANT, P
    GWYNNE, D
    [J]. NATURE, 1993, 362 (6418) : 312 - 318
  • [48] MEMBRANE-ANCHORED GROWTH-FACTORS
    MASSAGUE, J
    PANDIELLA, A
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 515 - 541
  • [49] No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas
    Menard, S
    Casalini, P
    Pilotti, S
    Cascinelli, N
    Rilke, F
    Colnaghi, MI
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (14) : 1002 - 1003
  • [50] Ménard S, 2002, CLIN CANCER RES, V8, P520